Managing anti-obesity medications: Everything obstetrician-gynecologists need to know Alexandra Karas, MA An ACOG 2024 symposium highlighted how clinicians can work with patients at every life stage to address weight management, including the potential use of anti-obesity medications
This article is for educational purposes only and does not replace the advice of a qualified healthcare or nutrition professional
distributed in 34.6%, 30.8%, 15.4%, and 19.2% in Liraglutide, semaglutide, dulaglutide, and control groups, respectively
Alanazi AM et al
If youre looking for a more aggressive approach to weight loss and have the ability to tolerate potential side effects, tirzepatide may be the better option due to its higher weight loss potential
In: Lett JT, Sinclair WK, editors